2-tert-butylhydroquinone has been researched along with Heart Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buelna-Chontal, M; Flores, PL; Garibay, C; Hernández-Reséndiz, S; Königsberg, M; Luna-López, A; Ostolga-Chavarría, M; Roldán, FJ; Silva-Palacios, A; Zazueta, C | 1 |
| Bi, X; Fang Liu, F; Jiang, F; Wang, S; Wu, X; Zhang, Y | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Heart Diseases
| Article | Year |
|---|---|
3-NP-induced Huntington's-like disease impairs Nrf2 activation without loss of cardiac function in aged rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Female; Heart Diseases; Huntington Disease; Hydroquinones; Neuroprotective Agents; NF-E2-Related Factor 2; Nitro Compounds; Oxidative Stress; Propionates; Rats, Wistar | 2017 |
The antioxidant compound tert-butylhydroquinone activates Akt in myocardium, suppresses apoptosis and ameliorates pressure overload-induced cardiac dysfunction.
Topics: Androstadienes; Animals; Antioxidants; Apoptosis; Arterial Pressure; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Diseases; Humans; Hydroquinones; Male; Mice; Myocardium; NF-E2-Related Factor 2; Oncogene Protein v-akt; Oxidative Stress; Phosphorylation; Wortmannin | 2015 |